$GNPX AUSTIN, Texas & CAMBRIDGE, Mass. & FARGO, N
Post# of 98051
(Total Views: 258)
Posted On: 09/27/2018 8:47:17 AM
$GNPX AUSTIN, Texas & CAMBRIDGE, Mass. & FARGO, N.D.--(BUSINESS WIRE)-- Genprex, Inc. (NASDAQ:GNPX), a clinical stage gene therapy company developing a new approach to treating cancer based upon a novel proprietary technology platform, has signed an agreement with Aldevron, a leading contract manufacturing organization, to supply TUSC2 (Tumor Suppressor Candidate2) plasmid DNA for use in Genprex’s clinical development program evaluating its immunogene therapy Oncoprex™ for the treatment of non-small cell lung cancer.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20180927005155/en/
https://www.otcmarkets.com/stock/GNPX/news/st...id=1181369
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20180927005155/en/
https://www.otcmarkets.com/stock/GNPX/news/st...id=1181369
(0)
(0)
Consider all my posts my opinion and not advice to buy or sell anything. I post on stocks I own or am considering owning. Do your own DD!
Scroll down for more posts ▼